Condition: EDTA



DESCRIPTION: Chelation therapy is a treatment that involves repeated intravenous (IV) administration of a chemical solution of ethylenediaminetetraacetic acid, or EDTA. It is used to treat acute and chronic lead poisoning by pulling toxins (including heavy metals such as lead, cadmium, and mercury) from the bloodstream. The word chelate comes from the Greek root chele, which means "to claw." EDTA has a claw-like molecular structure that binds to heavy metals and other toxins. EDTA chelation therapy is approved by the U.S. Food and Drug Administration (FDA) as a treatment for lead and heavy metal poisoning. It is also used as an emergency treatment for hypercalcemia (excessive calcium levels) and the control of ventricular arrhythmias (abnormal heart rhythms) associated with digitalis toxicity.

Diseases EDTA is associated with:

Heavy metal poisoning |

Symptoms associated with EDTA:

Affect immune function | Affect nerves | Chronic fatigue | Disruption of cellular enzymes | Memory loss | Nerve system damage | Premature aging |

List of EAP product(s) which may assist with EDTA :

ThioGel | ThioGel - L |




List of other EAP products:

OmniFlex | ThioGel | ThioGel - L |

 

Go back to RESOURCE HOME: Click here